Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#4230 Grade ≥3 subacute haematological toxicity with 177Lu-DOTATATE PRRT – Results from LUMEN study

Introduction: Bone marrow toxicity during peptide receptor radionuclide therapy (PRRT), results from radiation damage to haematopoietic tissue. Prospective comprehensive data on subacute haematological toxicity are scarce.

Conference:

Presenting Author: Mileva M

Authors: Mileva M, van Bogaert C, Ameye L, Flamen P, Karfis I,

Keywords: peptide receptor radionuclide therapy, GEP-NET, haematological toxicity,

#4097 Metabolic tumor volume (MTV) as a biomarker in patients with gastroenteropancreatic neuroendocrine neoplasms (GEPNENs): A multicentre study

Introduction: 18F-FDG PET/CT avidity predicts for higher histological grade and worse prognosis in patients with NEN. However, there is less evidence regarding the role of FDG-avid tumor volume in predicting prognosis.

Conference:

Presenting Author:

Authors: Chan D, Hayes A, Karfis I, Conner A, Mileva M,

Keywords: prognostic biomarker, PET imaging, 18F-FDG, metabolic tumor volume,

#3681 18F-FDG PET/CT-avid discordant volume as a biomarker in patients with gastroenteropancreatic neuroendocrine neoplasms – A multicentre study

Introduction: Dual 18F-FDG and 68Ga-DOTATATE PET/CT is emerging as a powerful technique to predict tumor biology. Whilst the presence of discordant disease (FDG avid/DOTA non-avid) predicts poor prognosis, it remains unknown whether the volume of discordant disease is also a significant predictor.

Conference:

Presenting Author: Chan D

Authors: Chan D, Hayes A, Karfis I, Conner A, Mileva M,

Keywords: prognostic biomarker, PET imaging, 18F-FDG, 68Ga-DOTATATE, dual PET, discordance,

#3178 Dual 68Ga-DOTATATE and 18F-FDG PET/CT in patients with gastroenteropancreatic neuroendocrine neoplasms: A multicentre, validation study of the NETPET score in 239 patients

Introduction: PET/CT using 68Ga-labelled somatostatin analogues and 18F-FDG have both been used to image neuroendocrine tumors. Our previously published data proposed the NETPET score to characterise findings on dual PET.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Chan D, Hayes A, Karfis I, Navalkissoor S, Furtado O’Mahony L,

Keywords: NETPET, prognostic biomarker, PET imaging, FDG, 68Ga-DOTATATE,